Overview
To systematically collect and analyse real-world data on treatment patterns, clinical outcomes and toxicities among patients with advanced pancreatic ductal adenocarcinoma (PDAC) undergoing systematic treatment in Austria
Description
1000 adult patients with locally advanced inoperable and/or metastasized PDAC undergoing first line chemotherapy
Eligibility
Inclusion Criteria:
- 18 years, female and male
- ECOG (Eastern Cooperative Oncology Group) Scale 0-2
- Diagnosis of histologically confirmed locally advanced inoperable and/or metastatic PDAC
- Patients undergoing palliative 1st line chemotherapy
- Signed informed consent for prospective patients, for retrospective cases no informed consent is required
Exclusion Criteria:
- Patients with locally advanced operable PDAC who do not receive palliative chemotherapy
- Patients with locally advanced borderline resectable PDAC who do not receive palliative chemotherapy